Smart sensor platform for respiratory health receives FDA clearance for home use

Strados Labs announced it received FDA clearance for home use of its smart sensor platform for respiratory health, according to a press release.
The RESP Smart Sensor Platform provides early, remote detection of key changes in lung acoustics and ventilation patterns to enable prediction of worsening respiratory diseases, according to the company. The platform detects lung sounds associated with asthma, COPD, heart failure and infectious diseases including COVID-19, according to the release.
The FDA clearance will allow users to track objective symptoms associated with pulmonary disease from

Strados Labs announced it received FDA clearance for home use of its smart sensor platform for respiratory health, according to a press release.
The RESP Smart Sensor Platform provides early, remote detection of key changes in lung acoustics and ventilation patterns to enable prediction of worsening respiratory diseases, according to the company. The platform detects lung sounds associated with asthma, COPD, heart failure and infectious diseases including COVID-19, according to the release.
The FDA clearance will allow users to track objective symptoms associated with pulmonary disease from